GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novelion Therapeutics Inc (STU:QLTA) » Definitions » Inventory Turnover

Novelion Therapeutics (STU:QLTA) Inventory Turnover : 1.17 (As of Mar. 2019)


View and export this data going back to . Start your Free Trial

What is Novelion Therapeutics Inventory Turnover?

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Novelion Therapeutics's Cost of Goods Sold for the three months ended in Mar. 2019 was €13.5 Mil. Novelion Therapeutics's Average Total Inventories for the quarter that ended in Mar. 2019 was €11.5 Mil. Novelion Therapeutics's Inventory Turnover for the quarter that ended in Mar. 2019 was 1.17.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Novelion Therapeutics's Days Inventory for the three months ended in Mar. 2019 was 78.14.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Novelion Therapeutics's Inventory-to-Revenue for the quarter that ended in Mar. 2019 was 0.40.

Novelion Therapeutics Inventory Turnover Historical Data

The historical data trend for Novelion Therapeutics's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novelion Therapeutics Inventory Turnover Chart

Novelion Therapeutics Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Inventory Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.38 4.61 4.26

Novelion Therapeutics Quarterly Data
Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19
Inventory Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.90 1.21 0.77 1.14 1.17

Novelion Therapeutics Inventory Turnover Calculation

Novelion Therapeutics's Inventory Turnover for the fiscal year that ended in Dec. 2018 is calculated as

Inventory Turnover (A: Dec. 2018 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (A: Dec. 2018 ) / ((Total Inventories (A: Dec. 2017 ) + Total Inventories (A: Dec. 2018 )) / count )
=52.474 / ((13.424 + 11.203) / 2 )
=52.474 / 12.3135
=4.26

Novelion Therapeutics's Inventory Turnover for the quarter that ended in Mar. 2019 is calculated as

Inventory Turnover (Q: Mar. 2019 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (Q: Mar. 2019 ) / ((Total Inventories (Q: Dec. 2018 ) + Total Inventories (Q: Mar. 2019 )) / count )
=13.469 / ((11.203 + 11.865) / 2 )
=13.469 / 11.534
=1.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novelion Therapeutics  (STU:QLTA) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Novelion Therapeutics's Days Inventory for the three months ended in Mar. 2019 is calculated as:

Days Inventory =Average Total Inventories (Q: Mar. 2019 )/Cost of Goods Sold (Q: Mar. 2019 )*Days in Period
=11.534/13.469*365 / 4
=78.14

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Novelion Therapeutics's Inventory to Revenue for the quarter that ended in Mar. 2019 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Mar. 2019 ) / Revenue (Q: Mar. 2019 )
=11.534 / 28.497
=0.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Novelion Therapeutics Inventory Turnover Related Terms

Thank you for viewing the detailed overview of Novelion Therapeutics's Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Novelion Therapeutics (STU:QLTA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novelion Therapeutics Inc (STU:QLTA) » Definitions » Inventory Turnover
Comparable Companies
DFFN TSXV:KLY TSXV:QPT ASX:PTX ROCO:4197 XSAT:WNT PTIX IST:RTALB TROV NOVN MATN LSE:TRX ASX:NYR ATOS TSXV:BCT JAGX TSX:CTX ROCO:6744 ACHV EMBI
Traded in Other Exchanges
N/A
Address
c/o Norton Rose Fulbright, 1800 West Georgia Street, Suite 510, Vancouver, BC, CAN, V6B 0M3
Website
http://www.novelion.com
Headquartered in Vancouver, Canada, QLT is a biotechnology company that researches and develops products used to treat conditions of the eye. After a recent board change, QLT divested its only marketed product, a laser treatment called Visudyne for the treatment of wet age-related macular degeneration and subfoveal choroidal neovascularization. QLT also earns royalty payments on other certain previously divested products. Following recent pipeline changes, the company currently has one product in development for two rare eye conditions.